Marketplace Analysis of Conjugated Estrogens: Determining the Consistently Present Steroidal Content with LC-MS
- PMID: 26242210
- PMCID: PMC4627451
- DOI: 10.1208/s12248-015-9805-x
Marketplace Analysis of Conjugated Estrogens: Determining the Consistently Present Steroidal Content with LC-MS
Abstract
Conjugated estrogens purified from pregnant mares urine has been used as estrogen hormone replacement therapy since 1942. Previously, methods were proposed to identify and quantify the components of this complex mixture but ultimately were withdrawn due to incomplete characterization of the product and difficulties in transferring the method between laboratories. The aim of the current study is to develop a LC method that can reliably detect multiple steroidal components in conjugated estrogen tablets and measure their relative amount. The method developed was optimized for UHPLC columns, and the elution profile was analyzed using high-resolution mass spectrometry. A total of 60 steroidal components were identified using their exact m/z, product ion spectra of known, and predicted conjugated estrogen structures. These components were consistently present in 23 lots of Premarin tablets spanning two production years. The ten conjugated estrogens identified in the USP monograph and other additional estrogens reported elsewhere are among the 60 steroidal components reported here. The LC-MS method was tested in different laboratories using multiple samples, and the obtained results were reproducible among laboratories.
Keywords: conjugated estrogens; mass spectrometry; steroidal content.
Figures




Similar articles
-
A systematic investigation to optimize simultaneous extraction and liquid chromatography tandem mass spectrometry analysis of estrogens and their conjugated metabolites in milk.J Chromatogr A. 2010 Jul 16;1217(29):4784-95. doi: 10.1016/j.chroma.2010.05.024. Epub 2010 May 25. J Chromatogr A. 2010. PMID: 20541211
-
Pharmacokinetic Study of Conjugated Equine Estrogens in Healthy Chinese Postmenopausal Women Using a Parallel Two-Column LC-MS/MS Method.Clin Pharmacokinet. 2022 Nov;61(11):1571-1583. doi: 10.1007/s40262-022-01177-4. Epub 2022 Sep 29. Clin Pharmacokinet. 2022. PMID: 36173592
-
Investigation of the temperature stability of premarin intravenous using liquid chromatography-mass spectrometry.J Pharm Biomed Anal. 2011 Jul 15;55(5):1218-22. doi: 10.1016/j.jpba.2011.03.003. Epub 2011 Mar 9. J Pharm Biomed Anal. 2011. PMID: 21444176
-
Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.J Pharm Biomed Anal. 2014 Jan;87:191-217. doi: 10.1016/j.jpba.2013.04.027. Epub 2013 Apr 28. J Pharm Biomed Anal. 2014. PMID: 23706957 Review.
-
Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.Clin Toxicol (Phila). 2012 Sep;50(8):733-42. doi: 10.3109/15563650.2012.713108. Epub 2012 Aug 13. Clin Toxicol (Phila). 2012. PMID: 22888997 Review.
Cited by
-
Chemometric Methods to Quantify 1D and 2D NMR Spectral Differences Among Similar Protein Therapeutics.AAPS PharmSciTech. 2018 Apr;19(3):1011-1019. doi: 10.1208/s12249-017-0911-1. Epub 2017 Nov 6. AAPS PharmSciTech. 2018. PMID: 29110294 Free PMC article.
-
Effect of a tissue selective estrogen complex on breast cancer: Role of unique properties of conjugated equine estrogen.Int J Cancer. 2018 Sep 1;143(5):1259-1268. doi: 10.1002/ijc.31401. Epub 2018 Apr 16. Int J Cancer. 2018. PMID: 29577272 Free PMC article.
References
-
- McEwen BS. Invited review: estrogens effects on the brain: multiple sites and molecular mechanisms. J Appl Physiol (1985) 2001;91(6):2785–801. - PubMed
-
- Wren BG, Brown LB, Routledge DA. Differential clinical-response to estrogens after menopause. Med J Aust. 1982;2(7):329–32. - PubMed
-
- Barrett-Connor E, Young R, Notelovitz M, Sullivan J, Wiita B, Yang HM, et al. A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women - Effects on bone mineral density, symptoms and lipid profiles. J Reprod Med. 1999;44(12):1012–20. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources